Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3676383014 | Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3676385019 | Alogliptin benzoate 6.25 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Alogliptin only product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing alogliptin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Alogliptin benzoate (substance) | false | Inferred relationship | Some | ||
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Alogliptin benzoate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Alogliptin benzoate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 6.25 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing alogliptin in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Alogliptin benzoate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR